Home > Uncategorized > Product Update: Google Pays $22.5 Million To Settle FTC Charges; FDA Approves Marqibo For Leukemia

Product Update: Google Pays $22.5 Million To Settle FTC Charges; FDA Approves Marqibo For Leukemia

August 10, 2012

Google will pay $22.5 million to settle FTC charges it misrepresented privacy assurances to Safari internet browser users in alleged violation of a Commission order.  For article, Click Here.

The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL).  For article, Click Here.

Dave Tate, Esq. (San Francisco)

Advertisements
Categories: Uncategorized